1
Radaelli Guido, Fleischer Daniel, Vick Bertrand, Caspari Matthew, Weissman Joseph, Rice David: Methods for concentrating microalgae. Aurora Biofuels, Radaelli Guido, Fleischer Daniel, Vick Bertrand, Caspari Matthew, Weissman Joseph, Rice David, WAHLSTEN Jennifer L, July 2, 2009: WO/2009/082696 (54 worldwide citation)

The present invention provides commercially viable, large-scale methods for concentrating microalgae with an average diameter of about 20 μm or less. The methods find use in concentrating microalgae with an average diameter of about 5 μm or less, for example, Nannochloropsis.


2
Mitchell John, Sandberg Jon, Sehler Dwight A, Williamson Michael, Rice David: Two-dimensional optical imaging methods and systems for particle detection. Particle Measuring Systems, Mitchell John, Sandberg Jon, Sehler Dwight A, Williamson Michael, Rice David, BARONE Stephen B, June 11, 2009: WO/2009/073652 (5 worldwide citation)

The present invention provides methods and systems for particle detection and analysis using two-dimensional optical imaging to access enhanced detection sensitivity and expanded sensing functionality relative to conventional point and array detection-based optical particle counters. Methods and sys ...


3

4
Mcleod Rima W, Muench Stephen P, Rafferty John B, Kyle Dennis E, Mui Ernest, Kirisits Michael, Mack Douglas G, Roberts Craig W, Samuel Benjamin, Lyons Russel E, Milhous Wilbur K, Rice David W, Prigge Sean: Fab i and inhibition of apicomplexan parasites. Mcleod Rima W, Muench Stephen P, Rafferty John B, Kyle Dennis E, Mui Ernest, Kirisits Michael, Mack Douglas G, Roberts Craig W, Samuel Benjamin, Lyons Russel E, Milhous Wilbur K, Rice David W, Prigge Sean, November 26, 2003: EP1363654-A2

Discovery and characterization of an apicomplexan Fab I gene and encoded enzyme and discovery of the triclosan as a lead compound, provide means to rationally design novel inhibitory compositions useful for prevention and treatment of apicomplexan related diseases.


5

6
Stilborn Heather L, Crum Roger C, Rice David W, Saunders Court A, Hinds Mark A, Ertl David S, Beach Larry R, Kleese Roger A, Huff William Edward: Method of reducing cholesterol in animals and eggs. Pioneer Hi Bred International, United States Department Of Agriculture, Stilborn Heather L, Crum Roger C, Rice David W, Saunders Court A, Hinds Mark A, Ertl David S, Beach Larry R, Kleese Roger A, Huff William Edward, HUMPHREY Christopher M, June 2, 2000: WO/2000/030469

The present invention provides a method of reducing cholesterol in animals and food products derived from such animals. The method includes feeding to the animals a low phytate food source so that the phytate phosphorus intake of the animal is reduced.


7
Little David, Good Elmer, Brough Chris, Taylor John, Rice David: Thermokinetic mixer, compositions and structural products. Little David, Good Elmer, Brough Chris, Taylor John, Rice David, BRACKEN David T, February 7, 2002: WO/2002/009861

The present invention comprises a novel thermokinetic mixer. In one form of the invention, the mixing chamber shaft projections are removable at least in part and replaceable without cutting the projections from the shaft. In another form of the invention, only a tip portion of such projections are ...


8
Mcleod Rima, Muench Stephen P, Rafferty John B, Kyle Dennis E, Mui Ernest J, Kirisits Michael J, Mack Douglas G, Roberts Craig W, Samuel Benjamin U, Lyons Russel E, Milhous Wilbur K, Rice David W, Prigge Sean: Fab i and inhibition of apicomplexan parasites. Mcleod Rima, Muench Stephen P, Rafferty John B, Kyle Dennis E, Mui Ernest J, Kirisits Michael J, Mack Douglas G, Roberts Craig W, Samuel Benjamin U, Lyons Russel E, Milhous Wilbur K, Rice David W, Prigge Sean, MARTIN Alice O, June 27, 2002: WO/2002/049576

Discovery and characterization of an apicomplexan $i(Fab I) gene and encoded enzyme and discovery of the triclosan as a lead compound, provide means to rationally design novel inhibitory compositions useful for prevention and treatment of apicomplexan related diseases.


9
Engel Paul C, Rice David: (De) Verfahren zur gezielten veränderung von enzymen, veränderte enzyme und deren verwendung, (En) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes. Degussa Aktiengesellschaft, Engel Paul C, Rice David, April 27, 1995: WO/1995/011296

(EN) Enzymes can usually be modified either by chemically changing the amino acids which constitute the enzyme or by mutation of the gene which codes for the enzyme. The method proposed by the invention is characterized by the following successive steps: the structure of at least two enzymes from a ...


10


Click the thumbnails below to visualize the patent trend.